TransAlta Announces C$350M Equity Offering to Fund US$1.0B Colorado Gas Portfolio Acquisition
Summary
TransAlta announced a C$350 million equity offering to partially finance its US$1.0 billion acquisition of two fully-contracted natural gas peaking facilities in Colorado, a move expected to be immediately accretive to free cash flow per share despite the dilution.
Key Events
-
US$1.0 Billion Acquisition Announced
TransAlta is acquiring two new natural gas-fired peaking facilities (Mountain Peak Power and Canyon Peak Power) in Colorado, totaling 318 MW of capacity, for US$1.0 billion. This follows a news announcement on the same day.
-
C$350 Million Equity Financing
The acquisition will be partially funded by a concurrent C$350 million bought deal equity financing, with a 15% over-allotment option. This represents approximately 5.9% of the company's current market capitalization, indicating substantial dilution.
-
Strategic & Accretive Assets
The acquired facilities are 100% contracted to investment-grade counterparties for 25+ years, expected to add US$80 million (C$110 million) in annual Adjusted EBITDA, and are projected to be immediately accretive to Free Cash Flow per Share.
-
Acquisition Closing Timeline
The acquisition is expected to close in early fourth quarter 2026.
Analysis
This filing details the financing for TransAlta's recently announced US$1.0 billion acquisition of two natural gas peaking facilities. The company plans a C$350 million bought deal equity financing to partially fund the deal, which will result in significant dilution for existing shareholders. However, the acquisition is strategic, adding 318 MW of 100% contracted capacity for 25+ years, and is expected to be immediately accretive to Free Cash Flow per Share and boost Adjusted EBITDA by C$110 million annually. This FWP provides critical financial specifics for a major corporate event.
At the time of this filing, TAC was trading at $13.80 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $9.93 to $17.88. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.